Anika Therapeutics (ANIK) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to -$3.2 million.
- Anika Therapeutics' Profit After Tax rose 8938.77% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.6 million, marking a year-over-year increase of 6543.07%. This contributed to the annual value of -$56.4 million for FY2024, which is 3179.26% up from last year.
- Latest data reveals that Anika Therapeutics reported Profit After Tax of -$3.2 million as of Q3 2025, which was up 8938.77% from -$4.6 million recorded in Q2 2025.
- Anika Therapeutics' Profit After Tax's 5-year high stood at $6.5 million during Q2 2021, with a 5-year trough of -$63.0 million in Q4 2023.
- Over the past 5 years, Anika Therapeutics' median Profit After Tax value was -$4.5 million (recorded in 2024), while the average stood at -$8.7 million.
- As far as peak fluctuations go, Anika Therapeutics' Profit After Tax soared by 18473.02% in 2021, and later tumbled by 118361.86% in 2023.
- Anika Therapeutics' Profit After Tax (Quarter) stood at -$5.8 million in 2021, then rose by 15.28% to -$4.9 million in 2022, then plummeted by 1183.62% to -$63.0 million in 2023, then skyrocketed by 65.29% to -$21.9 million in 2024, then soared by 85.48% to -$3.2 million in 2025.
- Its Profit After Tax stands at -$3.2 million for Q3 2025, versus -$4.6 million for Q2 2025 and -$4.9 million for Q1 2025.